Of note, it has been previously shown that increased IGF1R expression and the activation of its signaling system contribute to acquired bortezomib resistance in MM cell lines, which were progressively adapted to withstand high bortezomib concentrations [40]. The gene discussed is IGF1R; the disease is Miyoshi myopathy.